{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T04:29:12Z","timestamp":1794457752618,"version":"4.9.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T00:00:00Z","timestamp":1741996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T00:00:00Z","timestamp":1741996800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Health Econ Rev"],"DOI":"10.1186\/s13561-025-00609-8","type":"journal-article","created":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T06:42:18Z","timestamp":1742020938000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["A retrospective study \u201cmyo-inositol is a cost-saving strategy for controlled ovarian stimulation in non-polycystic ovary syndrome art patients.\u201d"],"prefix":"10.1186","volume":"15","author":[{"given":"Cesare","family":"Aragona","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel H.","family":"Myers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Salom\u00e9 Bezerra","family":"Espinola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Bilotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittorio","family":"Unfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,15]]},"reference":[{"issue":"6","key":"609_CR1","first-page":"555","volume":"14","author":"P Rizzo","year":"2010","unstructured":"Rizzo P, Raffone E, Benedetto V. Effect of the treatment with myo-inositol plus folic acid plus melatonin in comparison with a treatment with myo-inositol plus folic acid on oocyte quality and pregnancy outcome in IVF cycles. A prospective, clinical trial. Eur Rev Med Pharmacol Sci. 2010;14(6):555\u201361.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"11","key":"609_CR2","doi-asserted-by":"publisher","first-page":"857","DOI":"10.3109\/09513590.2011.564687","volume":"27","author":"V Unfer","year":"2011","unstructured":"Unfer V, Raffone E, Rizzo P, Buffo S. Effect of a supplementation with myo-inositol plus melatonin on oocyte quality in women who failed to conceive in previous in vitro fertilization cycles for poor oocyte quality: a prospective, longitudinal, cohort study. Gynecol Endocrinol. 2011;27(11):857\u201361.","journal-title":"Gynecol Endocrinol"},{"issue":"1","key":"609_CR3","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3109\/09513590.2015.1101444","volume":"32","author":"A Pacchiarotti","year":"2016","unstructured":"Pacchiarotti A, Carlomagno G, Antonini G, Pacchiarotti A. Effect of myo-inositol and melatonin versus myo-inositol, in a randomized controlled trial, for improving in vitro fertilization of patients with polycystic ovarian syndrome. Gynecol Endocrinol. 2016;32(1):69\u201373.","journal-title":"Gynecol Endocrinol"},{"issue":"3","key":"609_CR4","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1080\/09513590.2020.1760820","volume":"37","author":"MS Bezerra Espinola","year":"2021","unstructured":"Bezerra Espinola MS, Bilotta G, Aragona C. Positive effect of a new supplementation of vitamin D(3) with myo-inositol, folic acid and melatonin on IVF outcomes: a prospective randomized and controlled pilot study. Gynecol Endocrinol. 2021;37(3):251\u20134.","journal-title":"Gynecol Endocrinol"},{"issue":"3","key":"609_CR5","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/s43032-021-00829-3","volume":"29","author":"VA Kushnir","year":"2022","unstructured":"Kushnir VA, Smith GD, Adashi EY. The future of IVF: the new normal in human reproduction. Reprod Sci. 2022;29(3):849\u201356.","journal-title":"Reprod Sci"},{"issue":"Suppl 1","key":"609_CR6","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1002\/ijgo.14538","volume":"160","author":"D Gautam","year":"2023","unstructured":"Gautam D, Purandare N, Maxwell CV, Rosser ML, O\u2019Brien P, Mocanu E, et al. The challenges of obesity for fertility: A FIGO literature review. Int J Gynaecol Obstet. 2023;160(1):50\u20135.","journal-title":"Int J Gynaecol Obstet"},{"issue":"1","key":"609_CR7","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12958-023-01055-z","volume":"21","author":"D Greff","year":"2023","unstructured":"Greff D, Juh\u00e1sz AE, V\u00e1ncsa S, V\u00e1radi A, Sipos Z, Szinte J, et al. Inositol is an effective and safe treatment in polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials. Reprod Biol Endocrinol. 2023;21(1):10.","journal-title":"Reprod Biol Endocrinol"},{"key":"609_CR8","doi-asserted-by":"crossref","unstructured":"Wei J, Yan J, Yang H. Inositol nutritional supplementation for the prevention of gestational diabetes mellitus: A systematic review and Meta-Analysis of randomized controlled trials. Nutrients. 2022;14(14).","DOI":"10.3390\/nu14142831"},{"key":"609_CR9","doi-asserted-by":"crossref","unstructured":"Etrusco A, Lagan\u00e0 AS, Chiantera V, Buzzaccarini G, Unfer V. Myo-inositol in assisted reproductive technology from bench to bedside. Trends in Endocrinology & Metabolism; 2023.","DOI":"10.1016\/j.tem.2023.09.005"},{"issue":"10","key":"609_CR10","first-page":"749","volume":"17","author":"A Ghasemi","year":"2019","unstructured":"Ghasemi A, Amjadi F, Masoumeh Ghazi Mirsaeed S, Mohammad Beigi R, Ghasemi S, Moradi Y, et al. The effect of Myo-inositol on sperm parameters and pregnancy rate in oligoasthenospermic men treated with IUI: A randomized clinical trial. Int J Reprod Biomed. 2019;17(10):749\u201356.","journal-title":"Int J Reprod Biomed"},{"key":"609_CR11","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3390\/ijms221910575","volume":"22","author":"S Dinicola","year":"2021","unstructured":"Dinicola S, Unfer V, Facchinetti F, Soulage CO, Greene ND, Bizzarri M, et al. Inositols: from established knowledge to novel approaches. Int J Mol Sci. 2021;22:19.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"609_CR12","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.tem.2018.09.001","volume":"29","author":"AS Lagan\u00e0","year":"2018","unstructured":"Lagan\u00e0 AS, Garzon S, Casarin J, Franchi M, Ghezzi F. Inositol in polycystic ovary syndrome: restoring fertility through a Pathophysiology-Based approach. Trends Endocrinol Metab. 2018;29(11):768\u201380.","journal-title":"Trends Endocrinol Metab"},{"issue":"6","key":"609_CR13","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1093\/humrep\/17.6.1591","volume":"17","author":"TT Chiu","year":"2002","unstructured":"Chiu TT, Rogers MS, Law EL, Briton-Jones CM, Cheung LP, Haines CJ. Follicular fluid and serum concentrations of myo-inositol in patients undergoing IVF: relationship with oocyte quality. Hum Reprod. 2002;17(6):1591\u20136.","journal-title":"Hum Reprod"},{"issue":"8","key":"609_CR14","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.tem.2020.04.003","volume":"31","author":"F Facchinetti","year":"2020","unstructured":"Facchinetti F, Espinola MSB, Dewailly D, Ozay AC, Prapas N, Vazquez-Levin M, et al. Breakthroughs in the use of inositols for assisted reproductive treatment (ART). Trends Endocrinol Metab. 2020;31(8):570\u20139.","journal-title":"Trends Endocrinol Metab"},{"issue":"1","key":"609_CR15","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3390\/pharmacy11010017","volume":"11","author":"A Mackay","year":"2023","unstructured":"Mackay A, Taylor S, Glass B. Inequity of access: scoping the barriers to assisted reproductive technologies. Pharmacy. 2023;11(1):17.","journal-title":"Pharmacy"},{"key":"609_CR16","unstructured":"Costs of healthcare treatments in Italy. [Available from: https:\/\/www.fecondazioneeterologaitalia.it\/fecondazione-assistita-come-avviene-quanto-costa-le-tecniche-e-le-leggi-in-italia\/"},{"issue":"1","key":"609_CR17","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.fertnstert.2013.09.005","volume":"101","author":"GM Chambers","year":"2014","unstructured":"Chambers GM, Hoang VP, Sullivan EA, Chapman MG, Ishihara O, Zegers-Hochschild F, et al. The impact of consumer affordability on access to assisted reproductive technologies and embryo transfer practices: an international analysis. Fertil Steril. 2014;101(1):191\u2013e84.","journal-title":"Fertil Steril"},{"issue":"4","key":"609_CR18","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/s00404-018-4861-y","volume":"298","author":"AS Lagan\u00e0","year":"2018","unstructured":"Lagan\u00e0 AS, Vitagliano A, Noventa M, Ambrosini G, D\u2019Anna R. Myo-inositol supplementation reduces the amount of gonadotropins and length of ovarian stimulation in women undergoing IVF: a systematic review and meta-analysis of randomized controlled trials. Arch Gynecol Obstet. 2018;298(4):675\u201384.","journal-title":"Arch Gynecol Obstet"},{"issue":"49","key":"609_CR19","doi-asserted-by":"publisher","first-page":"e8842","DOI":"10.1097\/MD.0000000000008842","volume":"96","author":"X Zheng","year":"2017","unstructured":"Zheng X, Lin D, Zhang Y, Lin Y, Song J, Li S, et al. Inositol supplement improves clinical pregnancy rate in infertile women undergoing ovulation induction for ICSI or IVF-ET. Med (Baltim). 2017;96(49):e8842.","journal-title":"Med (Baltim)"},{"key":"609_CR20","doi-asserted-by":"crossref","unstructured":"Revised. 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19(1):41\u2013\u20097.","DOI":"10.1093\/humrep\/deh098"},{"issue":"10","key":"609_CR21","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1111\/j.1471-0528.2012.03412.x","volume":"119","author":"A La Marca","year":"2012","unstructured":"La Marca A, Papaleo E, Grisendi V, Argento C, Giulini S, Volpe A. Development of a nomogram based on markers of ovarian reserve for the individualisation of the follicle-stimulating hormone starting dose in in vitro fertilisation cycles. BJOG. 2012;119(10):1171\u20139.","journal-title":"BJOG"},{"key":"609_CR22","unstructured":"Gonadotropin cost in Italy. [Available from: https:\/\/www.salute.gov.it\/portale\/news\/p3_2_1_1_1.jsp?lingua=italiano%26menu=notizie%26p=dalministero%26id=6404"},{"issue":"8","key":"609_CR23","first-page":"643","volume":"20","author":"F Seyedoshohadaei","year":"2022","unstructured":"Seyedoshohadaei F, Abbasi S, Rezaie M, Allahvaisi A, Jafar Rezaie M, Soufizadeh N, et al. Myo-inositol effect on pregnancy outcomes in infertile women undergoing in vitro fertilization\/intracytoplasmic sperm injection: A double-blind RCT. Int J Reprod Biomed. 2022;20(8):643\u201350.","journal-title":"Int J Reprod Biomed"},{"key":"609_CR24","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/1477-7827-10-52","volume":"10","author":"F Lisi","year":"2012","unstructured":"Lisi F, Carfagna P, Oliva MM, Rago R, Lisi R, Poverini R, et al. Pretreatment with myo-inositol in Non polycystic ovary syndrome patients undergoing multiple follicular stimulation for IVF: a pilot study. Reprod Biol Endocrinol. 2012;10:52.","journal-title":"Reprod Biol Endocrinol"},{"issue":"2","key":"609_CR25","doi-asserted-by":"publisher","first-page":"e039122","DOI":"10.1136\/bmjopen-2020-039122","volume":"11","author":"H Yang","year":"2021","unstructured":"Yang H, Zheng C, Zheng Q, Xu H, Li X, Hao M, et al. Controlled ovarian hyperstimulation for poor ovarian responders undergoing in vitro fertilisation\/intracytoplasmic sperm injection: a protocol for systematic review and bayesian network meta-analysis. BMJ Open. 2021;11(2):e039122.","journal-title":"BMJ Open"},{"issue":"4","key":"609_CR26","doi-asserted-by":"publisher","first-page":"340","DOI":"10.4103\/jhrs.jhrs_173_21","volume":"14","author":"HD Pai","year":"2021","unstructured":"Pai HD, Baid R, Palshetkar NP, Pai A, Pai RD, Palshetkar R. Oocyte Cryopreservation - Current scenario and future perspectives: A narrative review. J Hum Reprod Sci. 2021;14(4):340\u20139.","journal-title":"J Hum Reprod Sci"},{"issue":"1","key":"609_CR27","doi-asserted-by":"publisher","first-page":"49","DOI":"10.5935\/1518-0557.20170012","volume":"21","author":"M Roque","year":"2017","unstructured":"Roque M, Valle M, Kostolias A, Sampaio M, Geber S. Freeze-all cycle in reproductive medicine: current perspectives. JBRA Assist Reprod. 2017;21(1):49\u201353.","journal-title":"JBRA Assist Reprod"},{"issue":"1","key":"609_CR28","doi-asserted-by":"publisher","first-page":"e0169869","DOI":"10.1371\/journal.pone.0169869","volume":"12","author":"GL Dunietz","year":"2017","unstructured":"Dunietz GL, Holzman C, Zhang Y, Talge NM, Li C, Todem D, et al. Assisted reproductive technology and newborn size in singletons resulting from fresh and cryopreserved embryos transfer. PLoS ONE. 2017;12(1):e0169869.","journal-title":"PLoS ONE"},{"issue":"7","key":"609_CR29","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.3390\/life13071483","volume":"13","author":"GC Cermisoni","year":"2023","unstructured":"Cermisoni GC, Pisaturo V, Vanni VS, Minetto S, Pagliardini L, Masciangelo R, et al. Fertility preservation as an option for women with genetic disorders: insights from a SWOT analysis on elective oocyte freezing and preimplantation genetic testing. Life. 2023;13(7):1483.","journal-title":"Life"},{"issue":"1","key":"609_CR30","doi-asserted-by":"publisher","first-page":"17789","DOI":"10.1038\/s41598-023-44055-0","volume":"13","author":"A Beresniak","year":"2023","unstructured":"Beresniak A, Russo M, Forte G, Lagan\u00e0 AS, Oliva MM, Aragona C, et al. A Markov-model simulation of IVF programs for PCOS patients indicates that coupling myo-Inositol with rFSH is cost-effective for the Italian health system. Sci Rep. 2023;13(1):17789.","journal-title":"Sci Rep"},{"key":"609_CR31","doi-asserted-by":"crossref","unstructured":"Kamenov Z, Gateva A. Inositols in PCOS. Molecules. 2020;25(23).","DOI":"10.3390\/molecules25235566"},{"issue":"10","key":"609_CR32","first-page":"e30351","volume":"14","author":"A Purwar","year":"2022","unstructured":"Purwar A, Nagpure S. Insulin resistance in polycystic ovarian syndrome. Cureus. 2022;14(10):e30351.","journal-title":"Cureus"},{"issue":"6","key":"609_CR33","first-page":"2001","volume":"83","author":"JE Nestler","year":"1998","unstructured":"Nestler JE, Jakubowicz DJ, de Vargas AF, Brik C, Quintero N, Medina F. Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system. J Clin Endocrinol Metab. 1998;83(6):2001\u20135.","journal-title":"J Clin Endocrinol Metab"},{"issue":"19","key":"609_CR34","doi-asserted-by":"publisher","first-page":"7157","DOI":"10.3390\/ijms21197157","volume":"21","author":"V Unfer","year":"2020","unstructured":"Unfer V, Dinicola S, Lagan\u00e0 AS, Bizzarri M. Altered ovarian inositol ratios May account for pathological steroidogenesis in PCOS. Int J Mol Sci. 2020;21(19):7157.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"609_CR35","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1111\/1471-0528.14754","volume":"125","author":"J Pundir","year":"2018","unstructured":"Pundir J, Psaroudakis D, Savnur P, Bhide P, Sabatini L, Teede H, et al. Inositol treatment of anovulation in women with polycystic ovary syndrome: a meta-analysis of randomised trials. BJOG. 2018;125(3):299\u2013308.","journal-title":"BJOG"},{"key":"609_CR36","doi-asserted-by":"crossref","unstructured":"Russo M, Forte G, Montanino Oliva M, Lagan\u00e0 AS, Unfer V. Melatonin and Myo-Inositol: supporting reproduction from the oocyte to birth. Int J Mol Sci. 2021;22(16).","DOI":"10.3390\/ijms22168433"},{"issue":"5","key":"609_CR37","doi-asserted-by":"publisher","first-page":"101698","DOI":"10.1016\/j.jogoh.2020.101698","volume":"49","author":"L Nazari","year":"2020","unstructured":"Nazari L, Salehpour S, Hosseini S, Saharkhiz N, Azizi E, Hashemi T, et al. Effect of myo-inositol supplementation on ICSI outcomes among poor ovarian responder patients: A randomized controlled trial. J Gynecol Obstet Hum Reprod. 2020;49(5):101698.","journal-title":"J Gynecol Obstet Hum Reprod"},{"key":"609_CR38","unstructured":"ART cycles performed in Italy. in 2021 [Available from: https:\/\/www.salute.gov.it\/portale\/news\/p3_2_1_1_1.jsp?lingua=italiano%26menu=notizie%26p=dalministero%26id=6404"},{"key":"609_CR39","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1757-2215-7-11","volume":"7","author":"CP Barbosa","year":"2014","unstructured":"Barbosa CP, Cordts EB, Costa AC, de Oliveira R, de Mendon\u00e7a MA, Christofolini DM, et al. Low dose of rFSH [100 IU] in controlled ovarian hyperstimulation response: a pilot study. J Ovarian Res. 2014;7:11.","journal-title":"J Ovarian Res"},{"key":"609_CR40","doi-asserted-by":"crossref","unstructured":"Drakopoulos P, Santos-Ribeiro S, Bosch E, Garcia-Velasco J, Blockeel C, Romito A et al. The effect of dose adjustments in a subsequent cycle of women with suboptimal response following conventional ovarian stimulation. Front Endocrinol. 2018;9.","DOI":"10.3389\/fendo.2018.00361"}],"container-title":["Health Economics Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13561-025-00609-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13561-025-00609-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13561-025-00609-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T06:42:27Z","timestamp":1742020947000},"score":1,"resource":{"primary":{"URL":"https:\/\/healtheconomicsreview.biomedcentral.com\/articles\/10.1186\/s13561-025-00609-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,15]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["609"],"URL":"https:\/\/doi.org\/10.1186\/s13561-025-00609-8","relation":{},"ISSN":["2191-1991"],"issn-type":[{"value":"2191-1991","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,15]]},"assertion":[{"value":"27 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was granted from the Alma Res Fertility Center in Rome (Italy). The approval of study was recorded as n\u00b02\/2024 by the Institutional Review Board of ALMA RES IVF Center and conducted according to the ethical principles of the Declaration of Helsinki. Written consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"M.R, S.H.M, and V.U are employees of Lo.Li. pharma s.r.l. All other authors report no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20"}}